Novel technologies for improved slide quality of pancreatic fine-needle aspirates
Award amount
$301,009Program and phase
SBIR · Phase IAward year
2016Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- AFFINERGY, LLC
- Proposal award date
- 2016-07-01
- Contract end date
- 2018-06-30
- UEI
- YJQ6K1QMS488
- Solicitation number
- PA15-269
- Topic code
- 300
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- A novel peptide assay for hepcidin clinical monitoring
- A Rapid Point of Care Test for APOL1 Renal Risk Alleles
- Novel clinical assay to rapidly monitor posaconazole levels in plasma
- Immunoprofiling to develop a novel diagnostic array for cardiac sarcoidosis
- Rapid assay to monitor vancomycin levels at the point of care in hemodialysis patients
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- A platform for T-cell receptor mimic antibody generation modeled using pHLA-A*11:01 KRAS G12D
- Combinatorial pipeline for discovery of anti-GPCR Nanobodies
- Development of a GBP-based glycosylation analysis system
- Extended-release injectable gel for multi-day treatment of postoperative pain
- eMOA: A Multi-Omic Service for Mechanism of Action Determination in Drug Screening
Research funding history
75 SBIR/STTR records share this UEI (2005–2023). Reported award amounts total $59,804,968. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services